Skip to main content
. 2021 Feb 4;9:593677. doi: 10.3389/fcell.2021.593677

Figure 1.

Figure 1

PCAT6 is overexpressed in ovarian cancer tissues and correlates with poor prognosis of ovarian cancer patients. (A) Analysis of PCAT6 expression in primary ovarian cancer patient samples and matched normal fallopian tube samples based on GSE137238 data. (B) Analysis of PCAT6 expression in serous ovarian cancer tissues or ascites and benign tissues based on GSE143897 data. (C) Analysis of PCAT6 expression in The Cancer Genome Atlas (TCGA) ovarian cancer tissues and Genotype-Tissue Expression (GTEx) normal ovary tissues using the GEPIA web server. (D) Levels of PCAT6 expression in patients with different stages of ovarian cancer based on the GSE143897 dataset. (E–G) Kaplan–Meier Plotter results for OS, PFS, and PPS of ovarian cancer patients with low and high PCAT6 expression. *P < 0.05.